DOI:
10.1055/s-00000041
Neuropediatrics
LinksClose Window
References
Hennes EM, Baumann M, Schanda K. , et al; BIOMARKER Study Group.
Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
Neurology 2017;
89 (09) 900-908
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.